Debate: PhRMA and its relations with Gov, Academia, Doctors and Consumers_Oct 4-5
Two especially timely conferences focus on MEDICINE AND THE LAW:
Antipsychotics, Newer Isn’t BetterDrug_Washington Post front page
“a study published yesterday overturns conventional wisdom about antipsychotic drugs, which cost the United States $10 billion a year.”
Troubled Children Exposed to Psych Treatments Causing More Harm_ NYT
The most striking acknowledgement in this sad story underscores the shaky foundation upon which the field of child psychiatry rests is the following statement by a Harvard University child psychiatrist: "When she was almost 8… Haley met full criteria for virtually every mental disorder listed."
Alternative Medicine Cover story: Kids & Psychiatric Drugs: Big Pharma Comes to the Classroom
Alternative Medicine is a national magazine with 165,000 subscribers. It is also sold nationwide on newsstands. Its cover story, Nov/Dec, is Kids & Psychiatric Drugs: BIG PHARMA comes to the classroom!
Russian Psychiatry : Again a Weapon Against Dissenters_WashPost
No legitimate physician would use the physician’s professional license to help repressive government regimes intimidate dissidents.
2 letters Re: Dr. Nemeroff Failure to Disclose Conflicts of Interest_WSJ
Success in academic psychiatry is not measured in the improvement of patients' mental health, but rather in quantifiable commercial tender.How many grants one brings to the university, how many publications one churns out each year, and how many corporate and professional advisory boards one serves on–and how much money one…
Psychiatry’s Most Powerful Association Feeling the Heat_SCIENCE
Psychiatry’s most powerful and influential key opinion leaders who belong to the American College of Neuropsychopharmacology (ACNP) have been caught off guard. The ACNP leadership is scrambling to overcome the scorn it has received following public disclosure about multiple breaches of ethics and professional standards of conduct. The College and…
THE SCIENTIST–Former Head of UK Psychopharmacology says Money Didn’t Sway Dr. Nemeroff
A follow-up to news reports about the conflict of interest scandal that has engulfed not only Dr. Charles Nemeroff, former president and editor in chief of the official journal of the American College of Neuropsychopharmacology, but the College itself.
ACNP Journal Editor Quits Amid Exposure of Conflicts of Interest
A notice from The American College of Neuropsychopharmacology, the inner sanctum of biological–predominantly drug-centered psychiatry–informs the
membership of the resignation of Dr. Charles Nemeroff, the Editor-in-Chief of its journal, Neuropsychopharmacology.
Marketing Suicide by Misapplying Population Trends_No Competing Interests?
Suicide rates fluctuate. Like the stock market their rise and fall is not due to a single decisive cause, but rather to a confluence of complex factors.
Study: Antipsychotics Not Effective for Childhood Schizophrenia
Industry’s blockbuster sellers–the atypical antipsychotics performed WORSE than their cheaper, non-patented precursors.
Alleged ethical / financial breaches by UCI Psychiatrist drew scrutiny but no sanctions_LAT
"Even though clinical research is a noble and worthy activity, it’s very easy to lose your moral compass if your primary goal is the dollar amount of grant funding that you generate."